Patents Assigned to ARALEZ PHARMACEUTICALS TRADING DAC
  • Co-crystal of the PAR-1 receptor antagonists vorapaxar and aspirin
    Patent number: 9604971
    Abstract: This invention relates to a co-crystal of vorapaxar and aspirin. The inventive co-crystal antagonizes the PAR-1 receptor. This invention also provides for pharmaceutical compositions comprising the inventive co-crystal as well as potentially to methods for the treatment, amelioration or prevention of conditions that could be treated by antagonizing the PAR-1 receptor.
    Type: Grant
    Filed: July 17, 2014
    Date of Patent: March 28, 2017
    Assignee: ARALEZ PHARMACEUTICALS TRADING DAC
    Inventors: Scott Trzaska, Alicia V. Duran-Capece, Matthew Lamm